eMS News

MS and Stress: Recalibrating for the HolidaysA Conversation with Patricia Daily, LCSW People with MS frequently say that stress makes their MS symptoms worse, so the question is, does stress…

Earlier this month, the US Food and Drug Administration (FDA) approved alemtuzumab (Lemtrada, Genzyme, a Sanofi Company) for the treatment of relapsing forms of multiple sclerosis (MS). A company statement…

At the Education Summit, we opened the floor for Q & A for participants to ask questions related to the doctors presentations. The Q & A was recorded and we’ve…

People experiencing symptoms consistent with secondary-progressive multiple sclerosis may be eligible to participate in a clinical research trial of an investigational therapy, Siponimod.  A new Phase III clinical research trial,…

We recently chatted with one of our fantastic volunteers, Matt Tarpey. Matt was born and raised in Denver, Colorado. He was diagnosed with MS in 2008. He’s a big Broncos…

Last month neurologists from the Rocky Mountain MS Center joined 8,500 MS specialists who gathered in Boston to present findings on multiple sclerosis research. The Americas and European Committees for…

Poor adherence to medication regimens is a significant problem. According the World Health Organization, only 50 percent of patients worldwide who have chronic illnesses take their medication as it is…

Fiscal and Physical Interventions for Arthritis Sep 13, 2014 9:30 AM – 12:30 PM From the RMMSC: Our friends at the Arthritis Foundation – Colorado have extended an invitation to…